drugset / Trial / NCT00523289

Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block

NCT00523289 ↗

RandomizedParallel-groupTriple-blind

Summary

The purpose of this study is to determine if bupivacaine (75% levobupivacaine plus 25% racemic bupivacaine) with vasoconstrictor is effective and safety as ropivacaine in brachial plexus block for orthopedic surgery.

Timeline

Start
2007-10
Primary completion
2009-03
Completion
2009-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 150 mg —
Comparator Ropivacaine Other / unclassified 150 mg —

Indications

No indication recorded.